Home Business Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

by admin

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk’s oral semaglutide, and helped patients lose more weight.Original Article

You may also like

Leave a Comment

14 + 15 =